Published in Gene Therapy Weekly, December 28th, 2000
The discovery reveals a mechanism critical for supporting brain development, learning, and memory, and a possible target for treating mental retardation and nerve damage following stroke and spinal cord injury.
The finding, reported in the November 17, 2000, issue of Science, indicates that the protein, PSD-95, helps build the physical scaffolding of the synapse that cells use to transmit the chemical messenger, or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.